CAS 627518-40-5

Indeno[1,2-c]pyrazol-3-amine,N-(3-fluorophenyl)-1,4-dihydro-6,7-dimethoxy-

Description:

Indeno[1,2-c]pyrazol-3-amine, N-(3-fluorophenyl)-1,4-dihydro-6,7-dimethoxy- is a chemical compound characterized by its complex structure, which includes an indeno-pyrazole core and a substituted phenyl group. This compound typically exhibits properties such as moderate solubility in organic solvents and potential bioactivity, making it of interest in medicinal chemistry. The presence of the fluorine atom in the phenyl group may enhance its pharmacological properties by influencing lipophilicity and metabolic stability. The methoxy groups contribute to the compound's electronic properties and steric hindrance, which can affect its interaction with biological targets. As a member of the pyrazole family, it may exhibit various biological activities, including anti-inflammatory or anticancer effects, although specific biological data would depend on empirical studies. Overall, this compound represents a class of heterocyclic compounds that are often explored for their potential therapeutic applications.

Formula: C₁₈H₁₆FN₃O₂

Synonyms:

• (6,7-Dimethoxy-1,4-dihydroindeno[1,2-c]pyrazol-3-yl)(3-fluorophenyl)amine

JNJ-10198409

CAS: 627518-40-5

JNJ-10198409: selective ATP competitive PDGF-RTK inhibitor; IC50: PDGFR-β 4.2 nM, PDGFR-α 45 nM; antiangiogenic & antiproliferative.

Formula: C₁₈H₁₆FN₃O₂

Purity: 98.51%

Color and Shape: Solid

Molecular weight: 325.34

Ref: TM-T15616

N-(3-Fluorophenyl)-6,7-dimethoxy-1,4-dihydroindeno[1,2-c]pyrazol-3-amine

CAS: 627518-40-5

Formula: C₁₈H₁₆FN₃O₂

Purity: 97%

Molecular weight: 325.3369

Ref: IN-DA003R62

JNJ-10198409

CAS: 627518-40-5

Formula: C₁₈H₁₆FN₃O₂

Molecular weight: 325.34

Ref: 7W-GL5848

JNJ-10198409

CAS: 627518-40-5

JNJ-10198409

Purity: ≥95%

Molecular weight: 325.34g/mol

Ref: 54-BUP08595

PDGFR Tyrosine Kinase Inhibitor IV

CAS: 627518-40-5

PDGFR Tyrosine Kinase Inhibitor IV (PDGF-IV) is a protein gene that is used for the treatment of PDGF-BB related diseases. It inhibits the growth of cancer cells by inhibiting the production of PDGF and other growth factors, such as growth factor β1. PDGF-IV also has inhibitory properties against HIV infection. This drug modulates the immune response to HIV by suppressing proliferation and inducing apoptosis in T cells. The drug is also being studied for its potential role in chronic pulmonary diseases, including idiopathic pulmonary fibrosis.

Formula: C₁₈H₁₆FN₃O₂

Purity: Min. 95%

Molecular weight: 325.34 g/mol

Ref: 3D-CAB51840